ecrin-mdr-crcClinical2018IPD Sharing (as of February 2022): NoColorectal CancerColorectal NeoplasmsCirculating Tumor DNAAdjuvant ChemotherapyProgression Free SurvivalColorectal CancerColorectal NeoplasmsCirculating Tumor DnaAdjuvant ChemotherapyProgression Free SurvivalInterventionalhttps://newmdr.ecrin.org/Study/2290096Denmark10OxaliplatinECRIN MDRRecruitingfalseIMPROVE Intervention Trial Implementing Non-invasive Circulating Tumor DNA Analysis to Optimize the Operative and Postoperative Treatment for Patients With Colorectal CancerA open label 1:1 randomized phase II exploratory study investigating adjuvant therapy in patients with molecular biologically detectable residual disease after primary resection for localized colorectal tumors.2018-10-152290096NCT03748680